StockData
Zivo Bioscience, Inc. logo

Zivo Bioscience, Inc. (ZIVO) stock

ZIVOOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 1/30
$6.80+0.30 (+4.62%)

Close on Oct 19, 2026Market cap $25.96MP/E –Yield –

Zivo Bioscience enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Zivo Bioscience's enterprise value was $26.01M on Oct 19, 2026, against $53.43M a year earlier. Over the last 5 years it ranged from -$260.91K to $214.95M, with a median of $60.50M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$26.01M-21.9%
2025Dec 31, 2025$33.30M-55.5%
2024Dec 31, 2024$74.88M+11837.2%
2023Dec 29, 2023$627.32K-99.5%
2022Dec 30, 2022$138.17M-8.7%
2021Dec 31, 2021$151.36M-58.7%
2020Dec 31, 2020$366.18M+0.4%
2019Dec 31, 2019$364.89M+178.1%
2018Dec 31, 2018$131.20M+75.3%
2017Dec 29, 2017$74.86M-8.0%
2016Dec 30, 2016$81.38M+21.0%
2015Dec 31, 2015$67.27M+9.2%
2014Dec 31, 2014$61.61M-76.8%
2013Dec 31, 2013$265.58M+125.9%
2012Dec 31, 2012$117.58M-19.8%
2011Dec 30, 2011$146.58M–

More Zivo Bioscience figures

See a number that looks wrong?